Skye Bioscience (SKYE) Preferred Shares (2015)

Skye Bioscience (SKYE) posted quarterly Preferred Shares of $1.4 million for Q4 2015, down 15.88% quarter-over-quarter from $1.6 million in Q3 2015.

Skye Bioscience (SKYE) Preferred Shares (2015) Analysis & Trends

Skye Bioscience (SKYE) has reported Preferred Shares for 1 consecutive years, with $1.4 million the latest figure, recorded in Q4 2015.

In Q4 2015, Preferred Shares changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2015 stood at $1.4 million (changed N/A YoY), while the FY2015 annual figure was $1.4 million, changed N/A from the prior year.
Preferred Shares eased to $1.4 million in Q4 2015 per SKYE's latest filing, from $1.6 million in the prior quarter.
Across five years, Preferred Shares topped out at $1.6 million in Q3 2015 and bottomed at $400.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.95 Bn	132.10 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	-
3	Argenx Se	65.71 Bn	60.52 Bn	1.37 Bn	-
4	Moderna	60.45 Bn	55.31 Bn	52.00 Mn	-
5	BeOne Medicines	42.24 Bn	37.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.80 Bn	28.49 Bn	992.69 Mn	-
7	BioNTech SE	28.64 Bn	10.25 Bn	668.28 Mn	-
8	Insmed	27.61 Bn	26.45 Bn	358.27 Mn	-
9	Royalty Pharma	27.26 Bn	26.42 Bn	-	-
10	Skye Bioscience	10.75 Mn	10.75 Mn	-	-

Download Data